arrow
A

Anke L. Stuurman

p95 clinical and epidemiology services, leuven, belgium
H指数:11
被引数:1,023

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Real-world Effectiveness of Live Attenuated and Inactivated Influenza Vaccines in Children and Adolescents from 2003 to 2023: a Plain Language Summary of Publication

2003年至2023年儿童和青少年中减毒活疫苗和灭活流感疫苗的实际有效性:出版物的大白话总结

2025-10-170
OA
Real-world effectiveness of live attenuated influenza vaccines (LAIV) and inactivated influenza vaccines (IIV) in children from 2003 to 2023: a systematic literature review and network meta-analysis

2003年至2023年儿童使用减毒活流感疫苗(LAIV)和灭活流感疫苗(IIV)的实际效果:一项系统文献综述和网络Meta分析

2025-08-020
OA
Protection against COVID-19 hospitalisation conferred by primary-series vaccination with AZD1222 in non-boosted individuals: first vaccine effectiveness results of the European COVIDRIVE study and meta-regression analysis
2023-08-012
OA
Investigating confounding in network-based test-negative design influenza vaccine effectiveness studies-Experience from the DRIVE project

调查基于网络的测试阴性设计流感疫苗有效性研究中的混杂因素-来自DRIVE项目的经验

2022-12-228
OA
The value of public-private collaborative real-world evidence platforms to monitor vaccine performance post authorization: DRIVE-a European initiative

公私合作现实世界证据平台的价值,以监测疫苗性能授权后: 驱动-欧洲倡议

2022-10-278
OA
Estimating baseline rates of adverse perinatal and neonatal outcomes using a facility-based surveillance approach: A prospective observational study from the WHO Global Vaccine Safety Multi-Country Collaboration on safety in pregnancy
2022-08-012
OAAI